adagrasib
mirati
['sclc', 'adagrasib', 'nsclc']
medscape: adagrasib shows impressive data in metastatic nsclc pts w/krasg12c mutation. produced responses in 43% of previously treated patients with #nsclc containing a krasg12c mutation, with median os of 12.6 months. #asco22 
Make life a little bit more cheerful is my main goal. I love to laugh, make people happy, and share interesting articles about health.